… and arterial stiffness burden in a chronic kidney disease cohort with high cardiovascular risk: baseline characteristics of the impact of phosphate reduction on vascular …

NM Lioufas, E Pedagogos, CM Hawley… - American journal of …, 2020 - karger.com
… the effect of the phosphate binder lanthanum carbonate on intermediate cardiovascular
It is upregulated from an early stage of CKD and is an important biomarker in CKD-MBD. …

A randomized trial on the effect of phosphate reduction on vascular end points in CKD (IMPROVE-CKD)

ND Toussaint, E Pedagogos, NM Lioufas… - Journal of the …, 2020 - journals.lww.com
kidney function, and … of effect of phosphate binders on cardiovascular intermediate markers
in our study was consistent with an open-labeled clinical trial, which randomized 120 patients

… outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease  …

N Lioufas, ND Toussaint, E Pedagogos, G Elder… - BMJ open, 2019 - bmjopen.bmj.com
Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney
disease… calcium-based phosphate binders in patients with chronic kidney disease: a systematic …

Systematic review and meta-analyses of the effects of phosphate-lowering agents in nondialysis CKD

NM Lioufas, EM Pascoe, CM Hawley… - Journal of the …, 2022 - journals.lww.com
… those with cardiovascular disease, but normal kidney function, … effects on PWV between
the noncalcium phosphate binderphosphate binders also had uncertain effects on vascular

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3

A Bouma-de Krijger, FJ van Ittersum… - Clinical kidney …, 2019 - academic.oup.com
… that phosphate binder therapy in normophosphataemic patients with … effects of early treatment
of phosphate exposure in order to improve cardiovascular risks in all CKD Stage 3 patients

[HTML][HTML] The importance of phosphate control in chronic kidney disease

K Tsuchiya, T Akihisa - Nutrients, 2021 - mdpi.com
… in the early stage of CKD, suggesting possible phosphatephosphate binders to reduce
the level of FGF23 in patients … Taken together, the effect of phosphate binders on FGF23 …

[HTML][HTML] Modifying phosphate toxicity in chronic kidney disease

M Vervloet - Toxins, 2019 - mdpi.com
… , adapting phosphate binder types, using combination therapy, … In a small prospective trial
in patients with early stage CKD, … the detrimental cardiovascular consequences of phosphate

[HTML][HTML] The key role of phosphate on vascular calcification

M Cozzolino, P Ciceri, A Galassi, M Mangano… - Toxins, 2019 - mdpi.com
… -dialysis chronic kidney disease (CKD) patients, even in the early stage of the disease.
For … The idea to have iron-based phosphate binders beyond anemia treatment may help to …

[HTML][HTML] Protein-Bound uremic toxins lowering effect of sevelamer in Pre-Dialysis chronic kidney disease patients with hyperphosphatemia: a randomized controlled …

K Takkavatakarn, P Puapatanakul, J Phannajit… - Toxins, 2021 - mdpi.com
… Furthermore, despite the declined renal function, patients with early stage CKD were able
to … -based phosphate binders in reducing cardiovascular toxic substances in CKD patients. …

Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease

H Ogata, H Sugawara, M Yamamoto… - … of Atherosclerosis and …, 2024 - jstage.jst.go.jp
… A study of a cohort of patients with early-stage CKD in Korea … favorable effects of statins
might be compromised in patients … -free phosphate binders reduced cardiovascular events …